MetaADEDB 2.0 @ LMMD
Molsidomine
(XLFWDASMENKTKL-UHFFFAOYSA-N)
Structure
SMILES
CCO/C(=N/c1on[n+](c1)N1CCOCC1)/[O-]
Type(s)
Approved; Investigational
ATC code(s)
C01DX12
Molecular Formula:
C9H14N4O4
Molecular Weight:
242.232
Log P:
-0.5502
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
0
TPSA:
87.03
CAS Number(s):
25717-80-0
Synonym(s)
1.
Molsidomine
2.
Morsydomine
3.
Corpea
4.
Corvaton
5.
Duracoron
6.
Fali-Cor
7.
Korvatone
8.
MTW-Molsidomin
9.
Molsi 1A Pharma
10.
Molsi-AZU
11.
Molsi-Puren
12.
Molsibeta
13.
Molsicor
14.
Molsidain
15.
Molsidomin
16.
Molsidomin Heumann
17.
Molsidomin Stada
18.
Molsidomin Von Ct
19.
Molsidomin-Ratiopharm
20.
Molsihexal
21.
Molsiket
22.
SIN-10
23.
Sydnopharm
24.
Fali Cor
25.
Heumann, Molsidomin
26.
MTW Molsidomin
27.
Molsi AZU
28.
Molsi Puren
29.
Molsidomin Ratiopharm
30.
SIN 10
31.
SIN10
32.
Von Ct, Molsidomin
External Link(s)
MeSHD008981
PubChem Compound4238
5360788
5353788
BindingDB50248123
39912
ChEBI31861
92623
CHEMBLCHEMBL4059924
CHEMBL1329455
DrugBankDB09282
DrugCentral1831
KEGGdr:D01320
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Accidental overdoseOFFSIDES
2Acute Coronary SyndromeOFFSIDES
3Amnesia11527544CTD
4Anastomotic LeakOFFSIDES
5Angina Pectoris6407452CTD
6Aortic AneurysmOFFSIDES
7ApathyOFFSIDES
8Aphthous StomatitisOFFSIDES
9Autoimmune neutropeniaOFFSIDES
10Bile Duct StenosisOFFSIDES
11Blood Platelet Disorders1576049CTD
12Blood creatine phosphokinase increasedOFFSIDES
13Blood creatinine increasedOFFSIDES
14Blood lactate dehydrogenase increasedOFFSIDES
15Blood parathyroid hormone increasedOFFSIDES
16Blood sodiumOFFSIDES
17Bone painOFFSIDES
18Bronchoalveolar LavageOFFSIDES
19Candida pneumoniaOFFSIDES
20Cardiac procedure complicationOFFSIDES
21Cardioactive drug level increasedOFFSIDES
22Cardiovascular insufficiencyOFFSIDES
23Carotid Artery ThrombosisOFFSIDES
24Catalepsy9437770CTD
25Catheter related complicationOFFSIDES
26CholecystitisOFFSIDES
27Chronic Obstructive Airway DiseaseOFFSIDES
28Chronic left ventricular failureOFFSIDES
29Circumstance or information capable of leading to medication errorOFFSIDES
30Cytolytic hepatitisOFFSIDES
31Device dislocationOFFSIDES
32DiverticulitisOFFSIDES
33DiverticulosisOFFSIDES
34Ejection Fraction DecreasedOFFSIDES
35Electrocardiogram PQ interval prolongedOFFSIDES
36Electrocardiogram ST segment abnormalOFFSIDES
37Electrocardiogram repolarisation abnormalityOFFSIDES
38Electromechanical dissociationOFFSIDES
39EmbolismOFFSIDES
40EpistaxisOFFSIDES
41Erosive gastritisOFFSIDES
42ErythemaOFFSIDES
43Feeling ColdOFFSIDES
44Friedreich Ataxia23418481CTD
45GastroenteritisOFFSIDES
46Gastrointestinal infectionOFFSIDES
47Gastrointestinal tract adenomaOFFSIDES
48Gingival HyperplasiaOFFSIDES
49HyperparathyroidismOFFSIDES
50HypokinesiaOFFSIDES
51HyporeflexiaOFFSIDES
52Left Ventricular HypertrophyOFFSIDES
53LeukoencephalopathyOFFSIDES
54Long QT SyndromeOFFSIDES
55LymphedemaOFFSIDES
56LymphoceleOFFSIDES
57Medical device complicationOFFSIDES
58Memory Disorders19373981CTD
59MonoparesisOFFSIDES
60Occult blood positiveOFFSIDES
61ParaplegiaOFFSIDES
62Performance status decreasedOFFSIDES
63PericarditisOFFSIDES
64PeritonitisOFFSIDES
65Prostatic calcificationOFFSIDES
66RalesOFFSIDES
67RhabdomyolysisOFFSIDES
68Rheumatoid factor increasedOFFSIDES
69Subcutaneous AbscessOFFSIDES
70Sudden deathOFFSIDES
71Suture ruptureOFFSIDES
72Troponin I increasedOFFSIDES
73Ventricular FibrillationOFFSIDES
74Vitamin A DeficiencyOFFSIDES
75Wound dehiscenceOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.